FGF19 and chronic kidney disease: In soleus, CKD mice were characterized by a higher expression of fast myosin genes (Myh4 (p < 0.05) and Myh1 (p = 0.11)) when compared to Sham animals, and FGF19 treatment tended to reduce this overexpression.